Aratana Therapeutics (PETX) Tops Q3 EPS by 10c

November 3, 2016 5:02 PM EDT
Get Alerts PETX Hot Sheet
Trade PETX Now!
Join SI Premium – FREE

Get inside Wall Street with StreetInsider Premium. Claim your 2-week free trial here.

Aratana Therapeutics (NASDAQ: PETX) reported Q3 EPS of ($0.38), $0.10 better than the analyst estimate of ($0.48). Revenue for the quarter came in at $40 thousand versus the consensus estimate of $80 thousand.

For earnings history and earnings-related data on Aratana Therapeutics (PETX) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Earnings

Related Entities

Earnings

Add Your Comment